Biohacking Autism with Nadia Elkhatib.

Nadia Elkhatib
  • 5.0 (10)
  • Health & Fitness
  • Updated Weekly

Hosted by Nadia Elkhatib, Biohacking Autism is the go-to podcast for parents, caregivers, and families navigating the complex world of autism. Each week, we explore the biological root causes behind the toughest challenges in autism, from autism anxiety and sleep disruption to neuroinflammation, MCAS, gut health, seizures, and nervous system dysregulation, alongside evidence-informed integrative approaches that actually help. We also cover caregiver health and longevity for parents raising autistic children, because your health matters just as much as your child's. From caregiver burnout and stress management to practical longevity strategies, these episodes are for the parent who is running on empty and ready to invest in themselves, too. Whether you're just beginning your autism journey or deep into biomedical interventions, this podcast gives you the research, the real talk, and the practical tools to make informed decisions for your child and for yourself. Popular Topics Include: autism anxiety, autism sleep, gut health autism, MCAS autism, neuroinflammation, nervous system dysregulation, peptides for autism, functional medicine autism, integrative health autism, caregiver health, autism parent burnout, caregiver burnout, longevity for parents, caregiver longevity, autism supplements, sensory processing, autism diet, autism parent support, vagus nerve stimulation autism, bioregulators for autism, HRV training for caregivers This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

  1. 1d ago ·  Video

    Autism Brain Development: The Building Blocks Behind Myelin, Plasmalogens and Alzheimer's | Dr. Dayan Goodenowe

    What does the brain need to build itself, and why does the answer matter for a child with autism and for the aging brain? In this episode of Biohacking Autism, Nadia Elkhatib talks with Dr. Dayan Goodenowe, PhD, neuroscientist, biochemist and founder of Prodrome Sciences, about autism brain development, white matter and myelination, mitochondrial dysfunction and brain inflammation in autism, and the lipid raw materials the brain needs to build itself, plasmalogens among them. Dr. Goodenowe reframes the developing brain as a wiring project. Myelin is the insulation that lets signals stay separate, and he explains why incomplete myelination can make a crowded room, a bright store or a loud classroom feel like every conversation arriving at once. He describes what he sees in the white matter of children with autism, why he views many autism-related changes as adaptation rather than attack, and where mitochondrial function and neuroinflammation fit in. From there the conversation turns to plasmalogens: what they do in the brain, why the body has to make them in peroxisomes, why you cannot simply eat them intact, and what plasmalogen precursors are. Nadia and Dr. Goodenowe then follow the same biology into the second half of life: cortical thickness as the brain's muscle, ApoE4 as a question of when rather than whether, what he measures in his testing and imaging work, and why caregiver brain health across decades belongs in the autism conversation. IN THIS EPISODE The brain as a wiring diagram: axons, synapses and myelinWhy myelination is adaptive and why deep sleep is part of itSensory overload explained through incomplete myelinationWhite matter, the corpus callosum and imaging in autismMitochondrial dysfunction and brain inflammation in autismMaternal metabolic health, discussed without blameWhat plasmalogens are and why they matter for the brainWhy plasmalogens cannot be eaten intact, and what precursors areAutism and Alzheimer's as two ends of the same biologyCortical thickness, brain volume and the aging brainApoE4 and when dementia starts, rather than whetherTesting, biomarkers and what a caregiver in their fifties might measureThe Moose Jaw, Saskatchewan community study CONNECT WITH DR. DAYAN GOODENOWE Dr. Dayan Goodenowe is a neuroscientist and biochemist, the founder of Prodrome Sciences, founder of Dr. Goodenowe's Dietary Therapeutics, and the author of Breaking Alzheimer's. Dr. Goodenowe's education site: https://drgoodenowe.com Prodrome Sciences (for practitioners): https://prodrome.com Dr. Goodenowe has a financial interest in Prodrome Sciences and in plasmalogen products discussed during this conversation. MEDICAL DISCLAIMER This episode is for educational and informational purposes only. It is not medical advice. Always consult with a qualified healthcare provider before making changes to your health protocol or your child's protocol. Several compounds and tests discussed in this episode are investigational or are not FDA-approved for the uses discussed. The plasmalogen precursor program described is in a pre-IND stage of an FDA-regulated development pathway. Biohacking Autism does not provide individualized treatment protocols, dosing instructions, or sourcing guidance for regulated compounds. This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

    Autism Brain Development: The Building Blocks Behind Myelin, Plasmalogens and Alzheimer's | Dr. Dayan Goodenowe

  2. 5d ago ·  Video

    20-MIN ESSENTIALS: Autism Tech, AI, AAC & 600+ Companies with Dan Feshbach

    More than 600 companies are building autism technology, yet most families have never heard of them. This 20-MIN ESSENTIALS edition condenses my conversation with Dan Feshbach, founder of Multiple and co-founder of TeachTown, into the core ideas families need most. Dan and I explore AI for autism, AAC, assistive technology, communication tools, sensory technology, and what it will take for useful technology to actually reach families. We also talk about why autism technology needs to move at the “speed of family,” why families need trusted tools rather than more shiny objects, and how emerging technology could support communication, work, connection, and greater independence. Dan shares the deeply personal reason this work matters to him. During a letterboard session, his son Reed described his experience in four words: “I live in silence.” His vision of a normal life was not about technology itself. It was about friendship, meaningful work, communication, independence, and being able to move through the world more freely. IN THIS ESSENTIALS EDITION: • Why autism technology needs to move at the “speed of family” • How AI can accelerate development and testing • Why 600+ autism technology companies remain largely invisible to families • The “first mile of capital” problem in autism innovation • Why families need trusted tools, not more shiny objects • AI-powered communication and support tools • Sensory eyewear and screen-free regulation technology • AAC and communication support for nonspeaking people • AI and biomedical pattern recognition • Brain-computer interfaces • Why technology should support a person's life, not become the life • Why waiting another 15 years for meaningful solutions is unacceptable WATCH THE FULL 67-MINUTE CONVERSATION: https://www.youtube.com/watch?v=fZjnQwfAhk0 CONNECT WITH DAN FESHBACH Multiple: https://www.multiplehub.org/ Multiple Autism-Tech Database: https://www.multiplehub.org/autism-tech-database CONNECT WITH BIOHACKING AUTISM Website: https://biohackautism.com/ Instagram: https://www.instagram.com/biohackautism/ LinkedIn: https://www.linkedin.com/in/nadiaelkhatib/ DISCLOSURE Dan Feshbach is the founder of Multiple and discusses companies and initiatives connected to Multiple's accelerator and autism-innovation ecosystem. Biohacking Autism has not independently evaluated or endorsed the companies, apps, devices, technologies, or research programs discussed in this episode. DISCLAIMER This program is for educational and informational purposes only and is not medical advice. Always consult a qualified healthcare professional before making changes to your health protocol or your child's protocol. Emerging technologies and research discussed in this episode may be investigational, early-stage, or not yet validated for autism. This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

    20-MIN ESSENTIALS: Autism Tech, AI, AAC & 600+ Companies with Dan Feshbach

  3. Sep 14 ·  Video

    The Hidden World of Autism Technology: AI, Communication, and 600+ Companies, with Dan Feshbach

    More than 600 companies are building autism technology, yet most families have never heard of them. What could change if AI, communication tools, sensory technology, and future neurotechnology reached the people who need them? Dan Feshbach, founder of Multiple and co-founder of TeachTown, joins Nadia Elkhatib to explore the hidden world of autism technology. They discuss what families actually need from innovation, why strong ideas often fail before they reach daily life, and how technology may support communication, connection, regulation, employment, and independence. Dan also shares the deeply personal experience that shaped his work. During a letterboard session, his son Reed described his experience in four words: “I live in silence.” His vision of a normal life was not about technology itself. It was about friendship, meaningful work, communication, independence, and being able to move through the world more freely. In this episode: • Why more than 600 autism technology companies remain largely invisible to families • AI and autism, including pattern recognition, faster prototyping, and the limits of current systems • AAC for autism and communication support for nonspeaking people • Assistive technology for autism, including augmented reality, sensory tools, haptic devices, distraction-filtering eyewear, and digital support characters • Why technology should support a person’s life rather than become the life • What makes a useful tool different from a shiny object • Why autism innovation faces a “first mile of capital” problem • What Multiple looks for in founders applying to its accelerator • What mission-aligned investors, donors, mentors, and limited partners can contribute • The future of brain-computer interfaces and minimally invasive communication technology • Why families cannot wait another 15 years for meaningful solutions CONNECT WITH DAN FESHBACH AND MULTIPLE Multiple: https://www.multiplehub.org/ Multiple Autism-Tech Database: https://www.multiplehub.org/autism-tech-database CONNECT WITH BIOHACKING AUTISM Website: https://biohackautism.com/ YouTube: https://www.youtube.com/@BiohackingAutism Instagram: https://www.instagram.com/biohackautism/ LinkedIn: https://www.linkedin.com/in/nadiaelkhatib/ Follow Biohacking Autism on your podcast app, and share this episode with someone who wants a clearer view of the technology, communication tools, and innovation being built for people with autism. DISCLOSURE Dan Feshbach is the founder of Multiple and discusses companies and initiatives connected to Multiple’s accelerator and autism-innovation ecosystem. Biohacking Autism has not independently evaluated or endorsed the companies, apps, devices, technologies, or research programs discussed in this episode. MEDICAL AND EDUCATIONAL DISCLAIMER This episode is for educational and informational purposes only. It is not medical advice. Always consult with a qualified healthcare provider before making changes to your health protocol or your child’s protocol. Emerging technologies and research discussed in this episode may be investigational, early-stage, or not yet validated for autism. ABOUT BIOHACKING AUTISM Biohacking Autism with Nadia Elkhatib explores complex questions affecting people with autism and the families who love them. Through expert conversations, lived experience, and evidence-aware discussion, the podcast examines communication, nervous-system regulation, caregiver health, emerging research, technology, and the practical decisions families face every day. This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

    The Hidden World of Autism Technology: AI, Communication, and 600+ Companies, with Dan Feshbach

  4. Sep 10 ·  Video

    Leucovorin for Autism? Trial, FRAA & FDA — 24-Min Essentials | John Slattery

    A shorter, focused edition of our full John Slattery conversation. Leucovorin, also known as folinic acid, has become one of the most discussed topics in autism research. John Slattery, co-author of the 2018 randomized double-blind placebo-controlled trial of folinic acid in children with autism and language impairment, joins Nadia Elkhatib to explain the essential findings in about 24 minutes. They cover what the trial actually measured, why language and communication mattered, folate receptor alpha autoantibodies (FRAAs), FOLR1, how folate reaches the brain, the reduced folate carrier, testing, and why some children may respond while others do not. John also clarifies what the FDA actually approved in 2026 — FOLR1-related cerebral folate transport deficiency — and why that is not the same as a broad FDA approval of leucovorin for autism. The conversation also addresses a practical question many families raise when their own clinician is unfamiliar with leucovorin, and John describes the access model being developed by Meadow Biosciences. This discussion is descriptive and educational; Biohacking Autism does not provide prescribing or medication-acquisition services. Want the complete science and context? Watch the full 1:41 conversation: https://www.youtube.com/watch?v=VP-Rm0XOLsg Connect with John Slattery Meadow Biosciences: https://www.meadowbiosciences.com/ Research & References 2018 Molecular Psychiatry randomized trial: https://www.nature.com/articles/mp2016168 FDA — FOLR1-related cerebral folate transport deficiency approval: https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-cerebral-folate-transport-deficiency American Academy of Pediatrics — leucovorin and autism interim guidance: https://www.aap.org/en/patient-care/autism/use-of-leucovorin-in-autistic-pediatric-patients/ Disclosure John Slattery is Co-founder, President, and CEO of Meadow Biosciences and has disclosed advisory relationships with BioTess Ingredients, Tesseract Medical Research, and Advanced Powder Dynamics. These relationships are disclosed for transparency. Medical Disclaimer This episode is for educational and informational purposes only. It is not medical advice or an individualized treatment recommendation. Leucovorin is a prescription medication. Individual testing and treatment decisions should be made with a qualified healthcare professional who knows the person’s medical history. This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

    Leucovorin for Autism? Trial, FRAA & FDA — 24-Min Essentials | John Slattery

  5. Sep 7 ·  Video

    Leucovorin and Autism: What the Folinic Acid Research Actually Shows | John Slattery

    Leucovorin, also known as folinic acid, has become one of the most discussed topics in autism research. John Slattery, co-author of the 2018 randomized double-blind placebo-controlled trial of folinic acid in children with autism and language impairment, joins Nadia Elkhatib to separate the research from the noise. They unpack what the trial actually measured and found; why folate receptor alpha autoantibodies (FRAAs) may matter; how FOLR1, cerebral folate deficiency, the folate receptor, and the reduced folate carrier affect folate transport to the brain; and why testing has to be interpreted in the context of the individual. John also explains the connections among folate metabolism, methylation, redox balance, and mitochondrial biology, along with the uncertainty around responder and non-responder profiles. They clarify the FDA’s 2026 approval of Wellcovorin (leucovorin calcium) for FOLR1-related cerebral folate transport deficiency — and why that is not the same as a broad FDA approval for autism. Connect with John Slattery Meadow Biosciences: https://www.meadowbiosciences.com/ Research & References 2018 Molecular Psychiatry randomized trial: https://www.nature.com/articles/mp2016168 FDA — FOLR1-related cerebral folate transport deficiency approval: https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-cerebral-folate-transport-deficiency American Academy of Pediatrics — leucovorin and autism interim guidance: https://www.aap.org/en/patient-care/autism/use-of-leucovorin-in-autistic-pediatric-patients/ Disclosure John Slattery is Co-founder, President, and CEO of Meadow Biosciences and has disclosed advisory relationships with BioTess Ingredients, Tesseract Medical Research, and Advanced Powder Dynamics. These relationships are disclosed for transparency. Medical Disclaimer This episode is for educational and informational purposes only. It is not medical advice or an individualized treatment recommendation. Leucovorin is a prescription medication. Discuss testing and treatment decisions with a qualified healthcare professional who knows the person’s medical history. This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

    Leucovorin and Autism: What the Folinic Acid Research Actually Shows | John Slattery

  6. Aug 31 ·  Video

    Scott Forsgren’s 16-Step Chronic Illness Roadmap: What Autism Families Can Learn

    When a child or adult with autism has multiple overlapping health concerns, where do you start, what comes next, and what may need to wait? Scott Forsgren, founder of BetterHealthGuy, joins Nadia to walk through the 16-step roadmap he developed from nearly three decades of navigating complex chronic illness, and to explore what autism families may be able to learn from that framework. The conversation begins with nervous system regulation, mast cells and histamine, detoxification and drainage, and the external environment. Scott then explains why sleep, movement, nutrition, the microbiome, mitochondria, immune modulation, coagulation, microbial burden, dental health, structure, and regeneration may belong in a broader sequence rather than a collection of disconnected interventions. They also discuss mold illness, Lyme disease, MCAS, sensitivity to interventions, why “more aggressive” is not always better, and how autism families can use a chronic-illness framework like this to ask better questions with qualified practitioners. Connect with Scott Forsgren BetterHealthGuy: https://www.betterhealthguy.com/ BetterHealthGuy Podcast: https://www.betterhealthguy.com/podcast Episode Resource Scott Forsgren’s 16-Step Health Recovery Framework and downloadable slides: https://www.betterhealthguy.com/steps Disclosure Scott Forsgren has disclosed relationships with FREmedica / WeAreNIKKI as an advisor, Ravel Health as an ambassador and investor, Prodrome as an affiliate, and advertising relationships through BetterHealthGuy. These relationships are disclosed for transparency. Medical Disclaimer This episode is for educational and informational purposes only. It is not medical advice. Always consult with a qualified healthcare provider before making changes to your health protocol or your child’s protocol. This discussion includes personal experiences, prescription and off-label references, emerging regenerative approaches, and category-level discussion of peptides and peptide bioregulators. It is not a recommendation or individualized treatment plan. This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

    Scott Forsgren’s 16-Step Chronic Illness Roadmap: What Autism Families Can Learn

  7. Aug 24 ·  Video

    Autism Gut Health: Peptide Signaling, Inflammation, and Oral Delivery | Kyal Van Der Leest

    Why can some peptides work orally while others struggle to survive the gut? In this episode of Biohacking Autism, Nadia Elkhatib talks with Kyal Van Der Leest, CEO, founder, and formulator of LVLUP Health, about autism gut health, peptide signaling, inflammation, oral bioavailability, and what formulation changes when peptides have to travel through the digestive system. Kyal starts with one of the clearest explanations of peptides we have heard on the podcast: “Amino acids are letters, peptides are words, and proteins are sentences.” From there, Nadia and Kyal explore why the size and structure of a peptide matter, what happens when peptides encounter stomach acid and digestive enzymes, and why delivery technologies such as delayed-release capsules may affect whether a compound survives long enough to act. They also go deeper into the gut barrier, tight junctions, histamine, inflammation, and the gut-brain connection. Kyal explains how he thinks about combining different compounds within a formulation, why some effects may remain local to the gut while others may be systemic, and how his approach to formulation has evolved as manufacturing and testing technology have improved. The conversation also explores Kyal’s personal experience with peptides, his family’s experience with brain health, Nadia’s experience navigating complex health issues with her son Jimmy, and the larger question at the center of Biohacking Autism: how do we better understand what is happening biologically beneath symptoms and behaviors? IN THIS EPISODE • What peptides are and how they signal in the body • Why some peptides are more difficult to deliver orally • Oral peptide bioavailability and absorption • The gut barrier, tight junctions, and intestinal permeability • Histamine, inflammation, and gut-brain signaling • Oral versus injectable peptide delivery • Why different peptides may be combined in a formulation • Peptides and brain health • Glutathione, neuroinflammation, and cognition • Formulation, manufacturing, and quality control • Why the sequence of interventions can matter in complex chronic health issues CONNECT WITH KYAL VAN DER LEEST Kyal Van Der Leest is the CEO, founder, and formulator of LVLUP Health. LVLUP Health: https://leveluphealth.com Kyal has a financial interest in LVLUP Health and in products discussed during this conversation. MEDICAL DISCLAIMER This episode is for educational and informational purposes only. It is not medical advice. Always consult with a qualified healthcare provider before making changes to your health protocol or your child’s protocol. Several compounds discussed in this episode are investigational or are not FDA-approved for the uses discussed. Biohacking Autism does not provide individualized treatment protocols, dosing instructions, or sourcing guidance for regulated compounds. This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

    Autism Gut Health: Peptide Signaling, Inflammation, and Oral Delivery | Kyal Van Der Leest

  8. Aug 17 ·  Video

    Autism Gut Issues and Bioregulators: A Clinical Pharmacist Explains | Dr. Grace Liu, PharmD

    Autism gut issues, the gut-brain axis, and bioregulators come together in this conversation with Dr. Grace Liu, PharmD. Grace explains why she approaches the gut and the brain as one interconnected system rather than working through them in sequence, what peptide bioregulators are and how they differ from signaling peptides, what the research actually shows, and why highly reactive children need a very different clinical lens. For most families the starting point is not theory. It is constipation, diarrhea, extreme food selectivity, and the behavior changes that seem to track alongside them. Grace talks through the microbiome picture underneath those symptoms, why some children react to almost everything including their own probiotics, and what she watches for when nothing is tolerated. She is also direct about the limits of the evidence. Much of the bioregulator literature sits outside peer-reviewed Western research, and she says so plainly rather than overselling it. The conversation closes on caregiver health, and why the twenty and thirty year horizon for parents belongs in the same roadmap as their kids. IN THIS EPISODE Why Grace approaches the gut and the brain as one system What separates a bioregulator from a signaling peptide What the research base actually looks like, and where it thins out Why reactive children need a different clinical lens Why caregiver longevity belongs in the same conversation "They have to be healed in parallel." Dr. Grace Liu, PharmD CONNECT WITH DR. GRACE LIU Instagram: https://www.instagram.com/gut_goddess/ TikTok: https://www.tiktok.com/@drgraceliu CONNECT WITH BIOHACKING AUTISM Website: https://biohackautism.com Instagram: @biohackautism TikTok: @biohackingautism YouTube: @BiohackingAutism LinkedIn: /in/nadiaelkhatib SUBSCRIBE Subscribe to Biohacking Autism for real solutions for people with autism and the ones who love them. PRODUCTS AND RESOURCES MENTIONED DISCLOSURE: Dr. Grace Liu is the founder of The Gut Institute and formulates and sells microbiome products discussed in this episode. The Gut Institute. Dr. Liu's clinical practice and clinician education platform, referenced throughout the conversation. Microbiome Mojo and Bifida Max. The probiotic formulations Dr. Liu developed and discusses on air. 7 Steps to Heal SIBO. Dr. Liu's book on small intestinal bacterial overgrowth. The published work of Professor Vladimir Khavinson. The peptide bioregulator research Dr. Liu trained under, and the origin of the cytamin, cytomax, and cytogen classification discussed in the episode. Partty A, Kalliomaki M, Wacklin P, Salminen S, Isolauri E. "A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial." Pediatric Research, 2015. https://pubmed.ncbi.nlm.nih.gov/25760553/ The study referenced on air. Worth opening rather than taking secondhand: it is a 75-infant pilot, which is useful context for how the finding lands in the conversation. The Profound Health Summit. The October peptide and bioregulator meeting Dr. Liu mentions she is speaking at. MORE FROM BIOHACKING AUTISM Episode 26 with Dr. Debby Hamilton on mast cell activation and MCAS Episode 16 with Dr. Krishna Doniparthi on the cell membrane Episode 2 on peptides and bioregulators ABOUT DR. GRACE LIU Dr. Grace Liu, PharmD is a clinical pharmacist with a doctorate in pharmacy and more than twenty years in practice. She is trained through A4M and IFM in regenerative and functional medicine, and she is the founder of The Gut Institute. Her work focuses on rebuilding the microbiome after the damage modern living does to it, using nutrigenomic tools, advanced testing, and peptides and bioregulators to address gut dysbiosis and chronic illness. She completed peptide and bioregulator training with Professor Vladimir Khavinson, is adjunct faculty at Peptide University and HealthMasters, and is the best-selling author of 7 Steps to Heal SIBO. She works with executive clients and elite athletes on lifespan, energy, and endurance, and she formulates her own products, including Microbiome Mojo and Bifida Max. MEDICAL DISCLAIMER This episode is for educational and informational purposes only. It is not medical advice. Always consult with a qualified healthcare provider before making changes to your health protocol or your child's protocol. Bioregulators, peptides, and the compounds discussed in this episode are not approved by the FDA for any use in the United States and carry no pediatric labeling. This conversation does not provide sourcing, dosing, or individualized recommendations, and nothing in it should be used as a plan for a specific child. Biohacking Autism with Nadia Elkhatib explores integrative and functional approaches to autism gut issues, the gut-brain axis, the microbiome, leaky gut, food sensitivities, and caregiver health, for people with autism and the ones who love them. This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

    Autism Gut Issues and Bioregulators: A Clinical Pharmacist Explains | Dr. Grace Liu, PharmD
See All (36)

5
out of 5
10 Ratings

About

Hosted by Nadia Elkhatib, Biohacking Autism is the go-to podcast for parents, caregivers, and families navigating the complex world of autism. Each week, we explore the biological root causes behind the toughest challenges in autism, from autism anxiety and sleep disruption to neuroinflammation, MCAS, gut health, seizures, and nervous system dysregulation, alongside evidence-informed integrative approaches that actually help. We also cover caregiver health and longevity for parents raising autistic children, because your health matters just as much as your child's. From caregiver burnout and stress management to practical longevity strategies, these episodes are for the parent who is running on empty and ready to invest in themselves, too. Whether you're just beginning your autism journey or deep into biomedical interventions, this podcast gives you the research, the real talk, and the practical tools to make informed decisions for your child and for yourself. Popular Topics Include: autism anxiety, autism sleep, gut health autism, MCAS autism, neuroinflammation, nervous system dysregulation, peptides for autism, functional medicine autism, integrative health autism, caregiver health, autism parent burnout, caregiver burnout, longevity for parents, caregiver longevity, autism supplements, sensory processing, autism diet, autism parent support, vagus nerve stimulation autism, bioregulators for autism, HRV training for caregivers This podcast uses the following third-party services for analysis: OP3 - https://op3.dev/privacy

Information

You Might Also Like